George Cardoza, Chief Financial Officer at SOPHiA GENETICS SA (SOPH), sold 1,403 shares at $4.85 ($7K) on 2026-04-08, disclosed to the SEC on 2026-04-10.
Scheduled sale ($7k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SOPH | BUY | 2026-06-05 | $99K | — | Filing → |
| SOPH | SELL | 2026-04-08 | $24K | — | Filing → |
| SOPH | SELL | 2026-03-20 | $7K | — | Filing → |